Drugs Made In America Acquisition II Corp
Today
Company Overview
Key Metrics
Price Target & Forecast
Analyst Ratings
Recent News
About Drugs Made In America Acquisition II Corp (DMII)
Drugs Made In America Acquisition II Corp trades under the ticker DMII on NASDAQ NMS - GLOBAL MARKET and operates in the N/A sector. Market capitalisation is around $647.83M. Over the past 52 weeks DMII has traded between $9.86 and $10.21. This page pulls together DMII's live quote, price history, key fundamentals and the EasyStox score so you can size up the company in one place.
DMII scores 63 out of 100 on the EasyStox score, a grade of C. The score blends analyst ratings, news sentiment, fundamentals, momentum and valuation into a single number. Its strongest area is price momentum, while valuation drags the score down the most.
DMII — frequently asked questions
What is the current DMII price?
Drugs Made In America Acquisition II Corp last traded at $10.17, -0.10% on the day. Prices on this page refresh automatically during market hours.
What is DMII's EasyStox score?
DMII currently scores 63 out of 100 (grade C). The score combines analyst ratings, news sentiment, fundamentals, momentum and valuation. It is research help, not a recommendation to buy or sell.
Is DMII a good investment?
EasyStox does not give buy or sell advice. What we can show you is the evidence: DMII's score breakdown, its valuation and fundamentals, how analysts rate it, and how the price has moved. Read those together with your own goals and time horizon before deciding.
What is DMII's P/E ratio?
DMII trades on a price-to-earnings ratio of about 77.31. A higher P/E means investors are paying more for each dollar of earnings, usually because they expect growth.